Administrative Core
行政核心
基本信息
- 批准号:10207345
- 负责人:
- 金额:$ 37.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-05 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:Administrative PersonnelAnimalsApplications GrantsAwardBioinformaticsCRISPR screenCRISPR/Cas technologyCaliberCellsClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicationCommunitiesConflict (Psychology)Conflict of InterestDataData AnalysesEnsureFundingGenetic ScreeningGoalsGrantGroup MeetingsGuidelinesHospitalsHumanHuman ResourcesHuman Subject ResearchImmunityIndividualInfrastructureInstitutesInstitutionLeadLeadershipManuscriptsMediatingMethodsMonitorOnline SystemsPilot ProjectsPreparationPrincipal InvestigatorProceduresProcessProgress ReportsPubMedPublic PolicyReportingResearch PersonnelResearch Project GrantsResearch SupportResolutionResource SharingScheduleScientistSecureServicesStructureSystemTeleconferencesTimeTravelUnited States National Institutes of HealthValidationacute infectionadaptive immune responsebasecareerconflict resolutiondata managementdata portaldata sharingin vivoinnovationinnovative technologiesmedical schoolsmeetingsmembermouse modelnoveloperationorganizational structureprogramsscreeningsuccessweb portal
项目摘要
The major objectives of the Administrative Core are to institute an infrastructure that facilitates
productive interactions among the U19 Program investigators of this grant application, “Defining
regulators of immunity to acute infection using CRISPR screens” and implements our Pilot Project
program. The Administrative Core will serve as a centralized, transparent organizational structure to
provide administrative support that enables the Principal investigators and their personnel to focus on
their experimental and scientific goals. Dr. Sharpe, Program Director of the overall U19 grant, will
provide leadership and direction for operations of the Administrative Core, which will be based at
Harvard Medical School. Dr. Haining, Co-Director of this U19 grant and Core A, will lead the Pilot Grant
Program. The Administrative Core will be responsible for carrying out the following functions: a) Provide
the infrastructure for overall management and co-ordination; b) Facilitate and promote interactions and
communication between program investigators, scientific advisors and administrative personnel; c) Plan
and coordinate annual External Scientific Advisory Group (ESAG) meetings; d) Organize and
coordinate travel for ESAG members; e) Assist the Program Directors and Principal Investigators with
oversight of scientific, fiscal, regulatory and compliance matters, and with preparation and review of
yearly progress reports and financial reports; f) Implement a plan for data management/sharing among
investigators; and g) Implement the Pilot Project Program. The Administrative Core will also resolve all
conflicts that may arise. To achieve these goals, Core A has the following specific aims: Aim 1: To
provide infrastructure for overall management and coordination. Core A will provide administrative
support and coordination to promote communication and interactions among Project and Core
investigators, including the scheduling of regular teleconferences/face-to-face meetings and annual
meetings, preparing and submitting annual progress reports, providing fiscal oversight and ensuring
institutional compliance with fiscal, regulatory and scientific issues, and conflict resolution. Aim 2: To
maintain a web-based portal for data sharing via a secure Dropbox. Core A will host and manage
a secure Dropbox portal for data sharing within the U19. This easy access to data will maximize
transparency, encourage collaboration, and aid in monitoring project progress and how collaborators
are utilizing core services. Aim 3: To implement the Pilot Project Program. Core A will develop an
effective process to solicit review and award high caliber innovative Pilot Projects that use our in vivo
CRISPR platform, and monitor their progress. We will encourage applications from early career
investigators. Through these specific Aims, we will create an Administrative Core structured to
implement processes/procedures to enable the success of this highly collaborative program.
行政核心的主要目标是建立一个基础设施,以促进
本次拨款申请的 U19 计划研究人员之间富有成效的互动,“定义
使用 CRISPR 筛选调节急性感染免疫力”并实施我们的试点项目
行政核心将作为一个集中、透明的组织结构,
提供行政支持,使主要研究人员及其人员能够专注于
他们的实验和科学目标是 U19 总体资助项目主任 Sharpe 博士。
为行政核心的运作提供领导和指导,该核心将设在
哈佛医学院 U19 资助项目联合主任兼核心 A 项目的海宁博士将领导试点资助项目
管理核心将负责执行以下职能: a) 提供
整体管理和协调的基础设施; b) 促进和促进互动;
c) 计划
并协调年度外部科学顾问小组 (ESAG) 会议;
协调 ESAG 成员的旅行; e) 协助项目主管和首席研究员
监督科学、财政、监管和合规事务,并准备和审查
f) 实施数据管理/共享计划
调查员;和 g) 实施试点项目计划还将解决所有问题。
为了实现这些目标,核心 A 有以下具体目标: 目标 1:
提供整体管理和协调的基础设施 核心 A 将提供行政管理。
支持和协调,促进项目和核心之间的沟通和互动
调查员,包括安排定期电话会议/面对面会议和年度会议
会议,准备和提交年度进度报告,提供财政监督并确保
财政、监管和科学问题的制度合规性以及冲突解决。
维护一个基于网络的门户,通过安全的 Dropbox Core A 进行数据共享并进行托管和管理。
用于在 U19 内共享数据的安全 Dropbox 门户,这种对数据的轻松访问将最大化。
透明度,鼓励合作,并帮助监控项目进展以及合作者如何
目标 3:实施试点项目计划 核心 A 将开发一个
有效的流程来征求审查并授予使用我们的体内的高水平创新试点项目
CRISPR 平台,并监控他们的进展,我们将鼓励早期职业生涯的应用。
通过这些具体目标,我们将创建一个行政核心,旨在
实施流程/程序,使这一高度协作的计划取得成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arlene H. Sharpe其他文献
The B7:CD28 family and friends: Unraveling coinhibitory interactions.
B7:CD28 家人和朋友:解开共抑制相互作用。
- DOI:
10.1016/j.immuni.2024.01.013 - 发表时间:
2024-02-01 - 期刊:
- 影响因子:32.4
- 作者:
Kelly P. Burke;A. Chaudhri;Gordon J. Freeman;Arlene H. Sharpe - 通讯作者:
Arlene H. Sharpe
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
B7-CD28/CTLA-4 共刺激途径的复杂性。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Schweitzer An;Arlene H. Sharpe - 通讯作者:
Arlene H. Sharpe
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model
小鼠同基因 CT2A 肿瘤模型中的抗原呈递缺陷、间质分化和免疫治疗耐药
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:7.3
- 作者:
J. Iorgulescu;Neil Ruthen;Ryuhjin Ahn;E. Panagioti;Prafulla C Gokhale;Martha R Neagu;M. Speranza;B. Eschle;Kara M. Soroko;R. Piranlioglu;Meenal Datta;S. Krishnan;K. Yates;Gregory J. Baker;Rakesh K Jain;M. Suvà;D. Neuberg;Forest M. White;E. Chiocca;Gordon J. Freeman;Arlene H. Sharpe;Catherine J Wu;David A. Reardon - 通讯作者:
David A. Reardon
Role of PD-1 in regulating acute infections.
PD-1 在调节急性感染中的作用。
- DOI:
10.1016/j.coi.2010.03.007 - 发表时间:
2010-06-01 - 期刊:
- 影响因子:7
- 作者:
Keturah E. Brown;Gordon J. Freeman;E. Wherry;Arlene H. Sharpe - 通讯作者:
Arlene H. Sharpe
Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders.
小鼠和人类 CTLA4 基因位点的完整序列测定:跨物种 DNA 序列相似性超出外显子边界。
- DOI:
10.1006/geno.1999.5930 - 发表时间:
1999-09-15 - 期刊:
- 影响因子:4.4
- 作者:
Vincent Ling;Paul W. Wu;H. Finnerty;Arlene H. Sharpe;Gary S. Gray;Mary Collins - 通讯作者:
Mary Collins
Arlene H. Sharpe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arlene H. Sharpe', 18)}}的其他基金
Defining regulators of immunity to acute infection using CRISPR screens
使用 CRISPR 筛选定义急性感染免疫调节因子
- 批准号:
10210502 - 财政年份:2020
- 资助金额:
$ 37.75万 - 项目类别:
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
项目2:治疗前、治疗期间以及耐药时的肿瘤和免疫微环境的测量和建模
- 批准号:
10343840 - 财政年份:2018
- 资助金额:
$ 37.75万 - 项目类别:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
简化靶向治疗可提高抗 PD-1 抑制剂对黑色素瘤的疗效
- 批准号:
9906872 - 财政年份:2018
- 资助金额:
$ 37.75万 - 项目类别:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
简化靶向治疗可提高抗 PD-1 抑制剂对黑色素瘤的疗效
- 批准号:
9576657 - 财政年份:2018
- 资助金额:
$ 37.75万 - 项目类别:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
简化靶向治疗可提高抗 PD-1 抑制剂对黑色素瘤的疗效
- 批准号:
10153453 - 财政年份:2018
- 资助金额:
$ 37.75万 - 项目类别:
Defining regulators of immunity to acute infection using CRISPR screens
使用 CRISPR 筛选定义急性感染免疫调节因子
- 批准号:
9380804 - 财政年份:2017
- 资助金额:
$ 37.75万 - 项目类别:
Defining regulators of immunity to acute infection using CRISPR screens
使用 CRISPR 筛选定义急性感染免疫调节因子
- 批准号:
10207344 - 财政年份:2017
- 资助金额:
$ 37.75万 - 项目类别:
Project 1: CRISPR screens to discover regulators of CD8 and CD4 cell fates and function
项目 1:通过 CRISPR 筛选发现 CD8 和 CD4 细胞命运和功能的调节因子
- 批准号:
10207349 - 财政年份:2017
- 资助金额:
$ 37.75万 - 项目类别:
Defining regulators of immunity to acute infection using CRISPR screens
使用 CRISPR 筛选定义急性感染免疫调节因子
- 批准号:
10266219 - 财政年份:2017
- 资助金额:
$ 37.75万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
Fosl2调控染色质开放性在哺乳动物卵丘-卵母细胞复合物成熟过程中的机制研究
- 批准号:82301863
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
H5亚型禽流感病毒PA蛋白诱导降解JAK1增强病毒对哺乳动物致病性的作用及机制研究
- 批准号:32373042
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
动物双歧杆菌对不同聚合度低聚木糖同化差异性的分子机制研究
- 批准号:32302789
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
相似海外基金
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
升级匹兹堡大学疫苗研究中心区域生物防护实验室的行政补充
- 批准号:
10631339 - 财政年份:2022
- 资助金额:
$ 37.75万 - 项目类别:
Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research
升级匹兹堡大学疫苗研究中心区域生物防护实验室的行政补充
- 批准号:
10631339 - 财政年份:2022
- 资助金额:
$ 37.75万 - 项目类别:
Metabolic Biomarkers for Fibromyalgia: Administrative Supplement
纤维肌痛的代谢生物标志物:行政补充
- 批准号:
10861142 - 财政年份:2020
- 资助金额:
$ 37.75万 - 项目类别: